List of works - Tilmann Bochtler

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.

scientific article published on 26 May 2017

Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.

scientific article published on 6 November 2015

Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experience

scientific article published on 03 April 2014

Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia

scientific article published on 23 September 2013

Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome

scientific article published on 29 April 2019

Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma

scientific article published on 01 October 2018

DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function

scientific article published on 30 July 2007

Diagnosis and management of metastatic neoplasms with unknown primary

scientific article

Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?

scientific article published on 17 May 2019

Enasidenib

scientific article published on 01 January 2018

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

scientific article published on 27 February 2008

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.

scientific article published on 20 February 2008

Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia

scientific article published on September 2016

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Bloo

scholarly article by Francesco Saraceni et al published 25 April 2019 in Journal of Hematology & Oncology

Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone

article by Tilmann Bochtler et al published 23 January 2014 in Amyloid

Hematological Malignancies in Adults With a Family Predisposition.

scientific article published in December 2018

Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).

scientific article published on 10 February 2011

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.

scientific article

Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial

scientific article published in 2020

In Reply

scientific article published on 01 April 2019

Integrated Histogenetic Analysis Reveals BAP1-Mutated Epithelioid Mesothelioma in a Patient With Cancer of Unknown Primary

scientific article published on 01 June 2018

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary

scientific article published on 11 March 2020

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

scientific article published on 18 May 2017

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

scientific article published on 24 January 2017

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

scientific article published on 12 November 2018

Mesenchymal stromal cells contribute to quiescence of therapy resistant leukemic cells in acute myeloid leukemia.

scientific article published on 11 August 2017

Micronucleus formation in human cancer cells is biased by chromosome size

article

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis

scientific article published on 24 March 2017

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

scientific article published on 20 March 2014

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia

scientific article published on 17 January 2019

Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

scientific article published on 08 June 2018

Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study

scientific article published on 2 June 2016

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

scientific article published on 27 December 2017

RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples

scientific article published on 05 September 2019

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

scientific article published on 01 March 2020

Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia